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Membrane protein-enriched extracellular vesicles
(MPEEVs) provide a platform for studying intact
membrane proteins natively anchored with the cor-
rect topology in genuine biological membranes.
This approach circumvents the need to conduct
tedious detergent screens for solubilization, purifica-
tion, and reconstitution required in classical mem-
brane protein studies. We have applied this method
to three integral type I membrane proteins, namely
the Caenorhabditis elegans cell-cell fusion proteins
AFF-1 and EFF-1 and the glycoprotein B (gB) from
Herpes simplex virus type 1 (HSV1). Electron cryoto-
mography followed by subvolume averaging allowed
the 3D reconstruction of EFF-1 and HSV1 gB in the
membrane as well as an analysis of the spatial distri-
bution and interprotein interactions on the mem-
brane. MPEEVs have many applications beyond
structural/functional investigations, such as facili-
tating the raising of antibodies, for protein-protein
interaction assays or for diagnostics use, as bio-
markers, and possibly therapeutics.
INTRODUCTION
Membrane proteins are a central subclass of the proteome
(Wallin and von Heijne, 1998). They are involved in many essen-
tial biological processes, including cell signaling, cell adhesion,
transport across the lipid bilayer, transduction of energy, and im-
mune response. As such, membrane proteins are implicated in
many disorders and are key targets for diagnostics and thera-
peutics. Prerequisite to conducting any research into membrane
protein function is the successful production of the protein of in-
terest in a functional form. Producing intact membrane proteins
is an inherently challenging task due to their requirement for a
lipid environment, and while remarkable achievements have
been made in the past several years toward the production of
membrane proteins, the requirement for lipidic environment re-
mains a severe restriction to the structure determination of these
otherwise desirable targets (Moraes et al., 2014). Most proce-
dures developed involve isolating the protein by detergent
solubilization, followed by a purification step and subsequentStrureconstitution into an artificial membrane e.g., liposomes, bi-
celles, or nanodiscs (Denisov et al., 2004; Whiles et al., 2002).
These procedures are highly time consuming and suffer from
further drawbacks, including low yields and high cost. Perhaps
most importantly, preserving the correct topology of membrane
proteins is often crucial for their function but is very difficult to
achieve during reconstitution experiments. Additionally, the bio-
logical relevance of in vitro model systems is limited by the rela-
tive simplicity of the lipid composition of the artificial membranes
when compared to native membranes that comprise a consider-
ably more diverse range of lipids, often with specific ratios that
can also form local subdomains (Simons and Ikonen, 1997).
Membrane enveloped viruses have been successfully used as
a platform for displaying intact membrane proteins on their sur-
face. This approach is referred to as pseudotyping, a process in
which the native virus surface protein is replaced with the protein
of interest. This gives rise tomembrane proteins that are properly
folded and oriented on cell-derived membranes. Vesicular sto-
matitis virus (VSV) is a favorable platform for the pseudotyping
approach with well-demonstrated success (Whitt, 2010). Sim-
pler systems that circumvent the related biosafety laboratory
requirements for work with VSV pseudotypes are virus-like par-
ticles (VLPs) that have been likewise applied successfully to
display membrane proteins (Noad and Roy, 2003). However,
an inherent limitation of the virus-based and VLP approaches
is the need for viral components. Additionally, integral mem-
brane proteins with bulky cytoplasmic domainswill not be readily
packed into either pseudotyped viruses or VLPs due to steric
hindrances from the virus capsid or matrix proteins. Further-
more, in these cases the cytoplasmic domain of the membrane
protein is potentially altered.
With the aforementioned limitations in mind, we have de-
veloped an alternative approach that provides high yields of
cell-derived, membrane protein-enriched extracellular vesicles
(MPEEVs). The basis for this approach is the utilization of the
recently characterized biological process of membrane vesicle
secretion (Gyo¨rgy et al., 2011). Extracellular vesicle secretion
seems to be a universal and evolutionary conserved process un-
der both physiological and pathological conditions. Chemical
vesiculants like paraformaldehyde in combination with dithio-
threitol can induce release of giant plasma membrane vesicles.
However, these agents have severe effects on the integrity of
the proteins and thus often limit the use of such preparations
to study membrane biophysics (Sezgin et al., 2012). The here
presented approach does not require any vesiculants or viral
components.cture 22, 1687–1692, November 4, 2014 ª2014 The Authors 1687
Figure 1. Analysis of MPEEVs by SDS-PAGE
(A) Vesicle preparation with Herpes simplex virus 1 (HSV1) glycoprotein B (gB).
gB appears as prominent band at a molecular weight of 110 kDa.
(B) Vesicle preparation with the C. elegans fusion proteins EFF-1 and AFF-1,
the proteins appear as predominant bands at a molecular weight of 97 kDa.
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MPEEV Production and Characterization
To produce extracellular vesicles enriched with a specific
membrane protein, adherent mammalian cells were transfected
with the gene corresponding to the full-length protein of interest
in a standard expression vector using an actin promoter. The
overexpression of the protein resulted in the accumulation of
MPEEVs in the growth medium (for details, see the Experimental
Procedures). The source compartment of the vesicles might
vary from protein to protein. The MPEEVs were then separated
from producer cells by differential centrifugation of the
supernatant.
We have applied this method to three integral membrane pro-
teins, namely the Caenorhabditis elegans cell-cell fusion pro-
teins AFF-1 and EFF-1 and the glycoprotein B (gB) from Herpes
simplex virus type 1 (HSV1). To estimate the relative enrichment
of the corresponding membrane protein in the MPEEVs, an
aliquot of the vesicle preparation was loaded on SDS-PAGE
(Figure 1). While some contaminants were observed, a major
band at the expected molecular weight was clearly apparent
for each of the three different samples. Based on the SDS-
PAGE, the estimated yield from one T175 flask was 50–
100 mg of protein. To further quantify the relative enrichment
and analyze the nature of the contaminants, the MPEEVsFigure 2. Visualization by of MPEEVs by Cryo-EM
Projection images of vesicles collected from the culture medium of cells transfe
full-length AFF-1 (B; defocus 5 mm); full-length EFF-1 (C; defocus 5 mm) and
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modified protein abundance index (emPAI) (Table 1). The emPAI
analysis verified that the corresponding membrane protein of in-
terest is the most abundant protein in the respective vesicle
preparation, correlating well with the SDS-PAGE results. Impor-
tantly, no other membrane proteins were detected and most of
the other proteins found were contaminants, either from the
serum added to the cell culture medium or from the transfection
reagent.
To characterize the protein incorporation in the membrane,
the vesicles were imaged with electron cryomicroscopy (cryo-
EM) and electron cryotomography (cryo-ET). The size and
morphology of the vesicles were dependent on the displayed
protein (Figure 2). For HSV1 gB and AFF-1, the vesicles were
mostly spherical and 100 nm in diameter. EFF-1 vesicles
were generally smaller in diameter and had variable morphol-
ogies. In the case of HSV1 gB, we observed elongated spikes
protruding from the membrane (16 nm; Figure 2A). In
the case of AFF-1 and EFF-1, the vesicle membranes were
uniformly covered with an 12–14 nm thick protein layer that
appeared to consist of discrete densities protruding radially out-
ward from the membrane (Figures 2B and 2C). In control vesicle
preparations, where the cells were transfected with an expres-
sion plasmid for cytosolic yellow fluorescence protein (YFP),
notably 1003 less vesicles were secreted. These vesicles
could be seen to display only very small, extra-membranous
densities, which were clearly different from those observed for
the MPEEVs (Figure 2D versus Figures 2A–2C). This indicates
that our experimental system is highly suitable for specifically
displaying topologically correct membrane proteins, and vesicle
secretion is induced by the expression of the membrane pro-
teins. Furthermore, to demonstrate the stability of these prepa-
rations, we have successfully imaged vesicles after storage in
buffer at 4C for over 2 months without noticing any decay.
This characteristic might be crucial for a number of nonstructural
applications.
Structure Determination from MPEEVs
To generate a 3D reconstruction of themembrane proteins in the
context of the membrane we have applied cryo-ET with subse-
quent averaging of tomographic subvolumes. Subvolume aver-
aging is a method of aligning and averaging a large number of
extracted volumes that contain the structure of interest, in order
to greatly improve the signal-to-noise ratio (Briggs, 2013; Fo¨rstercted with the expression plasmid for full-length HSV1 gB (A; defocus 3 mm);
cytosolic YFP (D; defocus 5 mm). Scale bar represents 100 nm.
s
Table 1. Major Proteins Identified by Mass Spectrometry in the Vesicles Preparations and Their Relative Abundance
Protein Namea
NCBI
Accession Mass (Da)
HSV1 gB AFF-1 EFF-1
Scoreb emPAIc
Rel. Abund.d
(%) Scoreb emPAIc
Rel. Abund.d
(%) Scoreb emPAIc
Rel. Abund.d
(%)
Envelope glycoprotein
B (HSV1)
1353200 100,875 16,873 70.91 27.6
Protein AFF-1 anchor
cell fusion failure-1
(C. elegans)
193204255 68,617 974 2.07 33
Protein EFF-1, isoform
a (C. elegans)
71982882 75,494 1004 1.66 16
Histone H2B homolog 156371481 24,545 225 1.78 28 392 1.78 17
Actin familye 178045 26,147 2,918 46.51 18.1 221 1.05 17 185 0.35 3
Hemoglobin fetal
subunit beta
62460494 15,963 998 33.03 12.9 95 0.78 12 234 1.62 15
Pyruvate kinase PKM 146345448 58,378 2,081 18.19 7.0
Tubulin beta-3 chain 12963615 50,842 1,422 17.00 6.6 134 0.37 3
14-3-3 protein zeta 82197807 27,929 625 16.42 6.4
Ras-related protein
Rap
75077355 21,040 356 13.03 5.1
Annexin A2 113951 38,937 1,730 12.89 5.0
T-complex protein 1
subunit zeta
115305833 58,376 405 10.15 4.0
Class-III intermediate
filaments
138535 53,754 1,500 9.64 3.8
Tubulin alpha 116256086 50,804 1,614 9.10 3.5
Histone cluster 1,
H2ag-like
291410763 27,347 141 1.00 10
Serum albumin 1351907 71,244 152 0.20 3 282 0.31 3
Galectin-3-binding
protein
81861611 65,270 272 0.41 7 315 0.63 6
60S acidic ribosomal
protein P2
133062 4,692 72 0.79 8
40S ribosomal protein
SA-like
296190805 32,906 182 0.47 4
Guanine nucleotide-
binding protein
subunit beta-2-like 1
5174447 35,511 170 0.56 5
Glyceraldehyde-3-
phosphate
dehydrogenase-like
488563203 35,942 190 0.55 5
Laminin-binding
protein
34234 31,888 197 0.49 5
aAll proteins other than gB of HSV1 and AFF-1 and EFF-1 of C. elegans are originating either from the BHK cells used to produce the vesicles or
contaminations, either from the serum added to the cell culture or transfection reagent.
bMascot score for confidence of protein identification is defined as the –log value of the probability P that this assignment is made by chance (Mackeen
et al., 2010).
cExponentially modified protein abundance index (emPAI) analysis (Ishihama et al., 2005; Trudgian et al., 2011).
dRelative abundance (Rel. Abund.) in respect to the proteins with the highest emPAI listed in this table.
eActin family representing gamma-actin, cytoplasmic actin 2, actin-cytoplasmic 1-like.
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Membrane Protein-Enriched Extracellular Vesicleset al., 2005). For the EFF-1 and gB structures (Figure 3), several
hundred subvolumes were automatically picked at the vesicle
surfaces using a local minimum search. These volumes were
then iteratively aligned and averaged in an unbiased, refer-
ence-free manner. The resulting 3D reconstruction of the elon-
gated spikes observed for gB showed a 3-fold symmetry andStruwas very similar to the postfusion crystal structure of gB (Held-
wein et al., 2006) and the 3D reconstruction of the ectodomain
bound to liposomes (Maurer et al., 2013) (Figure 3C). The result-
ing 3D reconstruction of natively-anchored EFF-1 had an asym-
metric elongated shape (Figure 3D). For further details on the
EFF-1 3D reconstruction, see Zeev-Ben-Mordehai et al. (2014).cture 22, 1687–1692, November 4, 2014 ª2014 The Authors 1689
Figure 3. 3D EM Reconstruction of the Pro-
teins on the Membrane
(A and B) Central and tangential slices through a
tomogram of MPEEVs displaying gB (A) and EFF-1
(B). Scale bar represents 50 nm.
(C and D) Isosurface representation of the sub-
volume reconstruction of gB with the trimer crystal
structure (Protein Data Bank [PDB]: 2GUM) fitted
(C) and EFF-1 EM map with a protomer of EFF-1
crystal structure (PDB: 4OJC) flexibly fitted (D),
side (left) and top views (right) are presented.
Membrane is shown in light blue; protein in or-
ange. Scale bar represents 5 nm.
(E and F) Isosurface representations of the to-
mograms shown in (A and B). The subvolume
reconstruction and the membrane were placed
back into the determined position and orientation
of individual protein spikes such enabling analysis
of relative orientations and interactions. Scale bar
represents 50 nm.
See also Movies S1 and S2.
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Membrane Protein-Enriched Extracellular VesiclesIn that study, it was shown that vesicles could have substantially
different morphologies, depending on the protein displayed and
the time point of harvest. Furthermore, imaging of vesicles un-
dergoing fusion revealed highly elusive membrane rearrange-
ments occurring during AFF-1- and EFF-1-mediated fusion
(Zeev-Ben-Mordehai et al., 2014).
Subvolume averaging, in addition to the 3D structure, pro-
vides the means to analyze the membrane proteins spatial dis-
tribution and to probe whether higher order assemblies are
apparent. This analysis was performed by subsequently back-
plotting the average structure into orientations and positions at
which the proteins were found on the membrane thus enabling
to visualize and assess the relative protein topology and inter-
protein interactions (Figures 3E and 3F; Movies S1 and S2 avail-
able online). For the examples presented, no ordered lattice or
preferred intermolecular interaction was observed in the case
of EFF-1. In the case of HSV1 gB some patches of trimers
showed preferred lateral interaction presumably mediated by
the trimer midregions as observed earlier for the soluble gB
ectodomain upon interaction with artificial liposomes (Maurer
et al., 2013).
In summary, the experimental system described here works
independent of detergents, vesiculants, and viruses, and as
such, we envisage MPEEVs being used in a broad number of ap-
plications. As the vesicles originate from cells, the intact mem-
brane protein is embedded in membranes with a native lipid
composition. MPEEVs can be potentially isolated from a wide
variety of cell-wall free cell types. The success in MPEEV pro-
duction relies on the overexpression of the protein of interest
and as a high level of expression is crucial, plasmids using a
strong promoter are required. The optimum time, posttransfec-
tion, for collecting the MPEEVs will vary for different proteins1690 Structure 22, 1687–1692, November 4, 2014 ª2014 The Authorsand needs to be determined case by
case. However, this optimization is very
fast and high quality material can be
produced within a week as opposed to
several months or even years required
for solubilization and reconstitution-based approaches. Here, results are presented for three type I
transmembrane proteins, the extent to which this method is
applicable for studying other families of membrane proteins re-
mains to be determined. As demonstrated here, the coupling
of this experimental system with techniques that are ideally
suited to study proteins within biological membranes such as
cryo-EM and cryo-ET enabled structural characterization of the
membrane protein of interest. Additionally, MPEEVs can be
used as highly protein-enriched, semipurified starting material
for classical detergent-based purification approaches currently
applied for structure determination by crystallography or NMR.
The applications for MPEEVs, however, are not limited to struc-
tural determination. They can credibly be used for a wide range
of exciting applications including antibody generation, protein-
protein interaction assays, diagnostics use, biomarkers, and
possibly therapeutics.
EXPERIMENTAL PROCEDURES
Vesicle Preparation
Adherent Baby Hamster Kidney cells (BHK-21, clone 13, ECACC 85011433)
were grown in a T175 flask; at 70% confluency, they were transfected with
either aff-1 (Avinoam et al., 2011), eff-1A (Avinoam et al., 2011), or HSV1 gB
(Pertel et al., 2001) gene in pCAGGS plasmid using Lipofectamine (Invitrogen).
Following a 2 hr incubation at 37C and 5% CO2, the medium with the trans-
fection reagent was removed and replaced by 2% FBS/GMEM-CM (Invitro-
gen). Transfected cells were allowed to grow for 24 hr or 48 hr at 37C and
5% CO2. Following the incubation, the medium was collected and cleared
from cell debris by centrifugation at 3,0003 g for 20 min and 4C. The vesicles
were pelleted through a 20% sucrose cushion at 100,000 3 g, and resus-
pended in 25 mM HEPES pH 7.4, 130 mM NaCl. For AFF-1 and EFF-1 vesicle
preparations each 19 independent repeats were performed for gB 11 indepen-
dent repeats were performed. For every vesicle preparation, 2 aliquots were
analyzed by cryo-EM.
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For the analysis of protein composition, vesicles were precipitated using chlo-
roform/methanol as described previously (Wessel and Flu¨gge, 1984) followed
by in-solution trypsin digestion (Xu et al., 2008). The mass spectrometry anal-
ysis was performed by nano ultraperformance liquid chromatography tandem
mass spectrometry (UPLC-MS/MS) using a nano Acquity UPLC system
coupled to a QTOF premier (Waters) as described previously (Mackeen
et al., 2010). MS/MS spectra were searched against the National Center for
Biotechnology Information (NCBI) database and proteins identified quantified
in a relative fashion using the empirically modified abundance index (emPAI)
approach as described (Ishihama et al., 2005; Trudgian et al., 2011) (Table
1). For each vesicle type (gB, EFF-1, AFF-1), mass spectrometry analysis
was performed from two independent preparations and found to be highly
similar. The data given in Table 1 is the result from one of these experiments.
Electron Cryo Microscopy Data Collection
Microscopy was performed at either 200 keV or 300 keV using a TF30 ‘‘Polara’’
electronmicroscope (FEI) equipped with a QUANTUM 964 postcolumn energy
filter (Gatan) operated in zero-loss imaging mode. A 50 mm C2 aperture and a
20 eV energy-selecting slit were used. Projection images and tilt series were
recorded on a 4 k3 4 k CCD camera or K2 summit direct detector at a nominal
magnification of 95,0003 or 77,0003 resulting in a calibrated pixel size of
0.38 nm or 0.28 nm at the specimen. Tilt series were collected at 200 kV or
300 kV using SerialEM (Mastronarde, 2005) at a defocus of –2 mm in 3 or 4
increments covering an angular range from –60 to 60. The total electron
dose for the tilt series was kept between 60 and 80 electrons/A˚2.
Tomographic Reconstructions
Tomographic reconstructions were calculated in IMOD (Kremer et al., 1996)
using weighted back-projection (Sandberg et al., 2003).
Subvolume Picking
Subvolumes were picked using a local minima search on 43 binned and
Gaussian-filtered versions of the tomograms as described (Zeev-Ben-Morde-
hai et al., 2014). In brief, all local minima with intensities lower than 2 SD below
the mean, and within 150 A˚ of the manually segmented vesicle membrane,
were considered as particles to be averaged, resulting in 1,973 subvolumes
for EFF-1 and 1,380 subvolumes for gB. Initial orientations of the sub-volume
‘‘boxes’’ were approximated as normal to the membrane. Using PEET version
1.9 (Nicastro et al., 2006), five iterations of alignment against the initial average
of all 1,973 subvolumes were performed on unmasked particles, in order to
refine the picking while aligning the membrane as well as the particle. For
EFF-1, the 801 subvolumes giving cross-correlation scores above the mean
were subsequently used for subvolume averaging. For gB, 748 subvolumes
from the two tomograms giving the most consistent averages were used. Us-
ing UCSF Chimera (Pettersen et al., 2004), the orientations and positions of
these subvolumes were visualized concurrently with the filtered tomogram
maps to validate the results of the picking process.
Subvolume Averaging
Averaging was performed using PEET version 1.9 (Nicastro et al., 2006). The
picked subvolumes for each protein were split into two evenly sized groups
(based on even and odd particle indices) for the averaging and the final FSC
calculation. For each of these four groups (two for EFF-1, two for gB) the
average of all particles in the group was used as the initial template. Six itera-
tions of refinement of the positions and orientations with successively finer
sampling increments while including progressively higher spatial frequency in-
formation were applied, with the particles masked to remove the membrane
and neighboring particles. The resulting structures from the two independent
refinements were aligned and the resolution determined using Fourier shell
correlation (FSC). The gB reconstruction went through four more iterations
of refinement with 3-fold symmetry applied.
The final structure, created by refining and averaging all 801 subvolumes for
EFF-1 and all 748 subvolumes for gB, was low-pass filtered using a Gaussian
curve with a width matching the FSC curve. The membrane structure from the
initial picking and the final particle structure were then plotted back into their
relative positions on the original tomogram.StruUCSF Chimera (Pettersen et al., 2004) was used for visualization, rigid body
fitting of the crystal structure, and preparation of the figures.
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